Clinical Trial Update: Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating abatacept and infliximab in combination with methotrexate for rheumatoid arthritis; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)
• Remicade (infliximab)
• Rheumatrex (methotrexate)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2011-01-21